LPTX no longer trades under this symbol. Its last trade on record was Apr 27, 2026. The price and figures on this page are from its last trading day and final filings, and are no longer updated.
Ranked by reported Q4 2024 13F market value
Share of total reported institutional value in LPTX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BIT Capital GmbH | 540K | $184K | — | 0.154% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in LPTX — a direct measure of their conviction.
Filings activity in LPTX during Q4 2024, grouped by how each filer changed its position.
No institutions trimmed their position this quarter.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q4 2024 | 1 | 98% | 0.15% | 8.15 pp | $0M | 100% |
| Q2 2021 | 41 | 15% | 8.30% | 0.78 pp | $56M | 21% |
| Q1 2021 | 48 | 7.7% | 9.08% | 2.99 pp | $71M | 36% |
| Q4 2020 | 52 | +18% | 12.07% | +6.05 pp | $112M | +128% |
| Q3 2020 | 44 | 14% | 6.02% | 1.03 pp | $49M | 19% |
| Q2 2020 | 51 | +89% | 7.05% | +4.34 pp | $61M | +244% |
| Q1 2020 | 27 | +59% | 2.71% | +1.91 pp | $18M | +378% |
| Q4 2019 | 17 | — | 0.80% | — | $4M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying LPTX stock.
Based on Q4 2024 13F filings, institutional ownership of Leap Therapeutics, Inc. stands at 0.1%, held across 1 reporting institutions.
BIT Capital GmbH is the largest reported institutional holder of LPTX, with approximately 540,000 shares worth $0.00B as of Q4 2024.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of LPTX.
Our composite Smart Money Score for LPTX is 42 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
1 institutions opened new positions in LPTX during Q4 2024, while 0 fully exited. 0 added to existing positions and 0 trimmed.
LPTX institutional ownership fell by 8.15 percentage points quarter-over-quarter, with a net change of +1 holders.
The top 10 institutions account for 100.0% of all reported 13F value in LPTX, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Leap Therapeutics, Inc. (LPTX) Institutional Ownership